Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Guerrero

Showing results (511-520 of 514) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 514 results.
Nature Communications|March 28, 2019
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerLuigi Formisano, Yao Lu, Alberto Servetto, et al.
Plos One|July 28, 2022
The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patientsA Cérbulo-Vázquez, M García-Espinosa, J C Briones-Garduño, et al.
Georgian Medical News|November 25, 2022
SAFETY AND EFFICACY OF THYMIC PEPTIDES IN THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS IN HONDURASH Ramos-Zaldívar, K Reyes-Perdomo, N Espinoza-Moreno, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 26, 2020
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDYEdgar Ortiz-Brizuela, Marco Villanueva-Reza, María F González-Lara, et al.
Pageof 52

Showing results (511-520 of 514) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 514 results.
Nature Communications|March 28, 2019
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerLuigi Formisano, Yao Lu, Alberto Servetto, et al.
Plos One|July 28, 2022
The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patientsA Cérbulo-Vázquez, M García-Espinosa, J C Briones-Garduño, et al.
Georgian Medical News|November 25, 2022
SAFETY AND EFFICACY OF THYMIC PEPTIDES IN THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS IN HONDURASH Ramos-Zaldívar, K Reyes-Perdomo, N Espinoza-Moreno, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 26, 2020
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDYEdgar Ortiz-Brizuela, Marco Villanueva-Reza, María F González-Lara, et al.
Pageof 52